STOCK NASDAQ US Healthcare

Halozyme Therapeutics, Inc.

HALO

Current Price

$71.53

-0.10% Today

Price History

Interactive Chart

6/7/2021 6/5/2026

Key Metrics

Market Cap $8.48B

P/E Ratio 25.10

Dividend Yield N/A

52W High $82.22

52W Low $51.06

Historical Returns

1 Year

+31.85%

3 Years

+106.02%

5 Years

+77.67%

About

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH